World Health Organization to help bring cheap biosimilar cancer drugs to poor Ruby Khatun Khatun7 May 2017 9:45 AM ISTThe World Health Organization (WHO) is to launch a pilot project this year to assess cheap copies of expensive biotech cancer drugs in a bid to make...
Strides Shasun's plant completes successful USFDA inspection Ruby Khatun Khatun7 May 2017 9:35 AM ISTNew Delhi: Drug firm Strides Shasun said the US health regulator has not made any observations after inspection of its manufacturing facility in...
Johnson & Johnson ordered to pay 110 million dollar in U.S. talc-powder trial Ruby Khatun Khatun6 May 2017 2:04 PM ISTJohnson & Johnson on Thursday was ordered by a Missouri jury to pay over $110 million to a Virginia woman who says she developed ovarian cancer...
Novartis exercises option with Conatus for NASH product Ruby Khatun Khatun6 May 2017 2:04 PM ISTNovartis is exercising its option with Conatus Pharmaceuticals for an exclusive license for the global development and commercialization of emricasan...
GE Healthcare Receives FDA Indication Approval for Visipaque™ (iodixanol) Injection for use with coronary CT angiography Ruby Khatun Khatun6 May 2017 1:49 PM ISTVisipaque is the first and only FDA-approved contrast agent indicated for non-invasive CCTA procedureChalfont St. Giles, UK: – Broadening its range of...
Medtronic Announces Worldwide Voluntary Field Corrective action for Newport Ventillators Ruby Khatun Khatun5 May 2017 12:30 PM ISTMedtronic is notifying customers worldwide of a voluntary field corrective action for all its Newport HT70 and Newport HT70 Plus ventilators...
Novartis, Roche back French gene therapy start-up Vivet Ruby Khatun Khatun5 May 2017 12:25 PM ISTFrench gene therapy start-up Vivet Therapeutics said on Thursday it had raised 37.5 million euros ($41 million) in an initial financing round, with...
Merck eyes key cancer drug growth as others lose patent protection Ruby Khatun Khatun5 May 2017 10:38 AM ISTMerck & Co Inc (MRK.N) on Tuesday reported better-than-expected profit in the first quarter as surprisingly strong demand for animal health...
AstraZeneca boosts early respiratory medicine with Pieris deal Ruby Khatun Khatun4 May 2017 11:33 AM ISTAstraZeneca boosted its early-stage respiratory medicine pipeline on Wednesday by signing a deal with Pieris Pharmaceuticals to develop novel inhaled...
Bayer, J&J win first trial over Xarelto bleeding risks Ruby Khatun Khatun4 May 2017 11:27 AM ISTA federal jury has cleared Bayer AG and Johnson & Johnson of liability in the first trial to flow out of thousands of lawsuits blaming injuries on...
Amgen Announces Expanded Commercial Collaboration With Novartis For Erenumab In Migraine Ruby Khatun Khatun4 May 2017 11:27 AM ISTCollaboration Designed to Maximize the Launch of First-in-Class Program and to More Effectively Reach People Living With MigraineTHOUSAND OAKS,...
Artificial Heart Maker gets approval to resume artificial heart implants trial Ruby Khatun Khatun3 May 2017 12:12 PM ISTArtificial heart maker Carmat has obtained approval from France's national drugs agency (ANSM) to resume heart implant trials, the company said on...
